Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 30, 2022
Blood pressure in persons with haemophilia with a focus on haemophilia-specific risk factors
Anna Ter-Zakarian, Richard F W Barnes, Rebecca Kruse-Jarres, et al.
Therapeutic Innovation & Regulatory Science
|
May 13, 2023
Statistical Considerations on the Use of RWD/RWE for Oncology Drug Approvals: Overview and Lessons Learned
Sunhee K Ro, Weidong Zhang, Qi Jiang, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 30, 2017
Patient powered prophylaxis: A 12-month study of individualized prophylaxis in adults with severe haemophilia A
Haowei Linda Sun, Kam A McIntosh, Sandra J Squire, et al.
Leukemia & Lymphoma
|
April 18, 2014
Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone
Haowei Linda Sun, Eshetu G Atenafu, Elizabeth Yeboah, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 5, 2002
The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors
Karla P Zeitz, Nicolas Guy, Annika B Malmberg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 23, 2021
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes
Haowei Linda Sun, Ming Yang, Man-Chiu Poon, et al.
Leukemia & Lymphoma
|
February 26, 2008
Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma
Paul Richardson, Constantine Mitsiades, Kathleen Colson, et al.
Research and Practice in Thrombosis and Haemostasis
|
October 20, 2021
The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B
Haowei Linda Sun, Ming Yang, Man-Chiu Poon, et al.
Research and Practice in Thrombosis and Haemostasis
|
April 7, 2022
Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real-world, multicenter, retrospective study
Davide Matino, Alfonso Iorio, Arun Keepanasseril, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 19, 2022
Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia
Na Li, Syed Mahamad, Sameer Parpia, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 30, 2022
Blood pressure in persons with haemophilia with a focus on haemophilia-specific risk factors
Anna Ter-Zakarian, Richard F W Barnes, Rebecca Kruse-Jarres, et al.
Therapeutic Innovation & Regulatory Science
|
May 13, 2023
Statistical Considerations on the Use of RWD/RWE for Oncology Drug Approvals: Overview and Lessons Learned
Sunhee K Ro, Weidong Zhang, Qi Jiang, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 30, 2017
Patient powered prophylaxis: A 12-month study of individualized prophylaxis in adults with severe haemophilia A
Haowei Linda Sun, Kam A McIntosh, Sandra J Squire, et al.
Leukemia & Lymphoma
|
April 18, 2014
Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone
Haowei Linda Sun, Eshetu G Atenafu, Elizabeth Yeboah, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 5, 2002
The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors
Karla P Zeitz, Nicolas Guy, Annika B Malmberg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 23, 2021
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes
Haowei Linda Sun, Ming Yang, Man-Chiu Poon, et al.
Leukemia & Lymphoma
|
February 26, 2008
Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma
Paul Richardson, Constantine Mitsiades, Kathleen Colson, et al.
Research and Practice in Thrombosis and Haemostasis
|
October 20, 2021
The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B
Haowei Linda Sun, Ming Yang, Man-Chiu Poon, et al.
Research and Practice in Thrombosis and Haemostasis
|
April 7, 2022
Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real-world, multicenter, retrospective study
Davide Matino, Alfonso Iorio, Arun Keepanasseril, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 19, 2022
Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia
Na Li, Syed Mahamad, Sameer Parpia, et al.
Page
of 6